• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

右美托咪定通过调控长链非编码 RNA 结肠癌相关转录本 1/微小 RNA-8063/Wnt/β-连环蛋白轴保护 H9C2 大鼠心肌细胞缺氧/复氧损伤。

Dexmedetomidine protects H9C2 rat cardiomyocytes against hypoxia/reoxygenation injury by regulating the long non-coding RNA colon cancer-associated transcript 1/microRNA-8063/Wnt/β-catenin axis.

机构信息

Department of Anesthesiology, Wuhan Fourth Hospital, Wuhan, Hubei, China.

出版信息

Bioengineered. 2022 May;13(5):13300-13311. doi: 10.1080/21655979.2022.2080420.

DOI:10.1080/21655979.2022.2080420
PMID:35635079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9275899/
Abstract

Dexmedetomidine (Dex) protects the heart from ischemia/reperfusion (I/R) injury. The differential expression of long non-coding RNAs (lncRNAs) is associated with myocardial injury, but whether the lncRNA colon cancer-associated transcript 1 (CCAT1) is associated with Dex-mediated myocardial protection remains unclear. In this study, a hypoxia/reoxygenation (H/R) H9C2 model was established to simulate the in vitro characteristics of I/R. CCAT1 and microRNA (miR)-8063 expression levels in H/R H9C2 cells pretreated with Dex were determined via quantitative reverse transcription-polymerase chain reaction. The survival and apoptotic rates of H9C2 cells were determined via cell counting kit-8 and flow cytometry assays. Wnt3a, Wnt5a, and β-catenin protein levels were measured via western blotting. Luciferase and RNA immunoprecipitation assays were used to explore the binding relationship between miR-8063 and CCAT1. Dex pretreatment increased H/R H9C2 cell viability and CCAT1 expression, while decreasing the cell apoptosis and Wnt3a, Wnt5a, and β-catenin protein levels. Knockdown of CCAT1 abolished the protective effects of Dex on H/R H9C2 cells, and the downregulation of miR-8063 expression eliminated the effect of CCAT1 knockdown. These results revealed that CCAT1, a sponge for miR-8063, is involved in Dex-mediated H9C2 cell H/R injury by negatively targeting miR-8063 and inactivating the Wnt/β-catenin pathway. Dex protects H9C2 cells from H/R impairment by regulating the lncRNA CCAT1/miR-8063/Wnt/β-catenin axis.

摘要

右美托咪定(Dex)可保护心脏免受缺血/再灌注(I/R)损伤。长链非编码 RNA(lncRNA)的差异表达与心肌损伤有关,但 lncRNA 结肠癌相关转录物 1(CCAT1)是否与 Dex 介导的心肌保护有关尚不清楚。本研究通过建立缺氧/复氧(H/R)H9C2 模型,模拟体外 I/R 特征。通过实时定量逆转录聚合酶链反应检测 Dex 预处理的 H/R H9C2 细胞中 CCAT1 和 microRNA(miR)-8063 的表达水平。通过细胞计数试剂盒-8 和流式细胞术检测 H9C2 细胞的存活率和凋亡率。通过 Western blot 检测 Wnt3a、Wnt5a 和β-catenin 蛋白水平。通过荧光素酶和 RNA 免疫沉淀试验探讨 miR-8063 与 CCAT1 的结合关系。Dex 预处理可增加 H/R H9C2 细胞活力和 CCAT1 表达,降低细胞凋亡和 Wnt3a、Wnt5a 和β-catenin 蛋白水平。CCAT1 敲低可消除 Dex 对 H/R H9C2 细胞的保护作用,而 miR-8063 表达下调则消除了 CCAT1 敲低的作用。这些结果表明,作为 miR-8063 海绵的 CCAT1 通过负向靶向 miR-8063 并使 Wnt/β-catenin 通路失活,参与 Dex 介导的 H9C2 细胞 H/R 损伤。Dex 通过调节 lncRNA CCAT1/miR-8063/Wnt/β-catenin 轴来保护 H9C2 细胞免受 H/R 损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4e/9275899/c156cbb1cee2/KBIE_A_2080420_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4e/9275899/447af3f9554a/KBIE_A_2080420_UF0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4e/9275899/04b19e6c97ae/KBIE_A_2080420_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4e/9275899/08a038f131f4/KBIE_A_2080420_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4e/9275899/716c33e0655c/KBIE_A_2080420_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4e/9275899/2c8a13c1832e/KBIE_A_2080420_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4e/9275899/c156cbb1cee2/KBIE_A_2080420_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4e/9275899/447af3f9554a/KBIE_A_2080420_UF0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4e/9275899/04b19e6c97ae/KBIE_A_2080420_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4e/9275899/08a038f131f4/KBIE_A_2080420_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4e/9275899/716c33e0655c/KBIE_A_2080420_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4e/9275899/2c8a13c1832e/KBIE_A_2080420_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a4e/9275899/c156cbb1cee2/KBIE_A_2080420_F0005_OC.jpg

相似文献

1
Dexmedetomidine protects H9C2 rat cardiomyocytes against hypoxia/reoxygenation injury by regulating the long non-coding RNA colon cancer-associated transcript 1/microRNA-8063/Wnt/β-catenin axis.右美托咪定通过调控长链非编码 RNA 结肠癌相关转录本 1/微小 RNA-8063/Wnt/β-连环蛋白轴保护 H9C2 大鼠心肌细胞缺氧/复氧损伤。
Bioengineered. 2022 May;13(5):13300-13311. doi: 10.1080/21655979.2022.2080420.
2
Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.右美托咪定通过 miR-208b-3p/Med13/Wnt 信号通路轴保护 H9C2 细胞对抗缺氧/复氧损伤。
Biomed Pharmacother. 2020 May;125:110001. doi: 10.1016/j.biopha.2020.110001. Epub 2020 Feb 25.
3
lncRNA CCAT2 Protects Against Cardiomyocyte Injury After Myocardial Ischemia/Reperfusion by Regulating BMI1 Expression.长链非编码 RNA CCAT2 通过调控 BMI1 表达减轻心肌缺血/再灌注损伤。
Int Heart J. 2024;65(2):279-291. doi: 10.1536/ihj.23-569.
4
Inhibition of miR-148b ameliorates myocardial ischemia/reperfusion injury via regulation of Wnt/β-catenin signaling pathway.抑制 miR-148b 通过调控 Wnt/β-catenin 信号通路改善心肌缺血/再灌注损伤。
J Cell Physiol. 2019 Aug;234(10):17757-17766. doi: 10.1002/jcp.28401. Epub 2019 Feb 28.
5
Dexmedetomidine protects hepatic cells against oxygen-glucose deprivation/reperfusion injury via lncRNA CCAT1.右美托咪定通过长链非编码 RNA CCAT1 保护肝细胞免受氧葡萄糖剥夺/再灌注损伤。
Cell Biol Int. 2018 Sep;42(9):1250-1258. doi: 10.1002/cbin.10996. Epub 2018 Jul 2.
6
Long noncoding RNA TALNEC2 regulates myocardial ischemic injury in H9c2 cells by regulating miR-21/PDCD4-medited activation of Wnt/β-catenin pathway.长链非编码 RNA TALNEC2 通过调控 miR-21/PDCD4 介导的 Wnt/β-catenin 通路激活调控 H9c2 细胞心肌缺血损伤。
J Cell Biochem. 2019 Aug;120(8):12912-12923. doi: 10.1002/jcb.28562. Epub 2019 Mar 12.
7
LncRNA AZIN1-AS1 ameliorates myocardial ischemia-reperfusion injury by targeting miR-6838-5p/WNT3A axis to activate Wnt-β/catenin signaling pathway.长链非编码 RNA AZIN1-AS1 通过靶向 miR-6838-5p/WNT3A 轴激活 Wnt-β/β-连环蛋白信号通路来改善心肌缺血再灌注损伤。
In Vitro Cell Dev Biol Anim. 2022 Jan;58(1):54-68. doi: 10.1007/s11626-022-00646-1. Epub 2022 Jan 21.
8
Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.右美托咪定通过调节 miR-665/MEF2D/Nrf2 轴抑制细胞焦亡减轻心肌缺血再灌注损伤。
Biomed Pharmacother. 2023 Sep;165:115255. doi: 10.1016/j.biopha.2023.115255. Epub 2023 Aug 5.
9
Long non-coding RNA FTX alleviates hypoxia/reoxygenation-induced cardiomyocyte injury via miR-410-3p/Fmr1 axis.长链非编码 RNA FTX 通过 miR-410-3p/Fmr1 轴缓解低氧/复氧诱导的心肌细胞损伤。
Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):396-408. doi: 10.26355/eurrev_202001_19938.
10
Long Noncoding RNA Taurine-Upregulated Gene 1 Knockdown Protects Cardiomyocytes Against Hypoxia/Reoxygenation-induced Injury Through Regulating miR-532-5p/Sox8 Axis.长链非编码RNA牛磺酸上调基因1敲低通过调控miR-532-5p/Sox8轴保护心肌细胞免受缺氧/复氧诱导的损伤。
J Cardiovasc Pharmacol. 2020 Nov;76(5):556-563. doi: 10.1097/FJC.0000000000000895.

引用本文的文献

1
Dexmedetomidine ameliorates diabetic intestinal injury by promoting the polarization of M2 macrophages through the MMP23B pathway.右美托咪定通过MMP23B途径促进M2巨噬细胞极化来改善糖尿病性肠损伤。
World J Diabetes. 2024 Sep 15;15(9):1962-1978. doi: 10.4239/wjd.v15.i9.1962.
2
Dexmedetomidine ameliorates x-ray-induced myocardial injury via alleviating cardiomyocyte apoptosis and autophagy.右美托咪定通过减轻心肌细胞凋亡和自噬改善 X 射线诱导的心肌损伤。
BMC Cardiovasc Disord. 2024 Jun 26;24(1):323. doi: 10.1186/s12872-024-03988-8.
3
Insight into Cardioprotective Effects and Mechanisms of Dexmedetomidine.

本文引用的文献

1
MiR-26a-5p Targets WNT5A to Protect Cardiomyocytes from Injury Due to Hypoxia/Reoxygenation Through the Wnt/β-catenin Signaling Pathway.miR-26a-5p 通过 Wnt/β-连环蛋白信号通路靶向 WNT5A 保护心肌细胞免受缺氧/复氧损伤。
Int Heart J. 2021 Sep 30;62(5):1145-1152. doi: 10.1536/ihj.21-054. Epub 2021 Sep 17.
2
MicroRNA‑8063 targets heterogeneous nuclear ribonucleoprotein AB to inhibit the self‑renewal of colorectal cancer stem cells via the Wnt/β‑catenin pathway.微小 RNA-8063 通过靶向异质核核糖核蛋白 AB 抑制结直肠癌细胞干细胞的自我更新,从而抑制 Wnt/β-连环蛋白通路。
Oncol Rep. 2021 Oct;46(4). doi: 10.3892/or.2021.8170. Epub 2021 Aug 13.
3
右美托咪定的心脏保护作用及机制研究
Cardiovasc Drugs Ther. 2024 Dec;38(6):1139-1159. doi: 10.1007/s10557-024-07579-9. Epub 2024 Jun 13.
Long non-coding RNA AK006774 inhibits cardiac ischemia-reperfusion injury via sponging miR-448.
长链非编码 RNA AK006774 通过海绵吸附 miR-448 抑制心脏缺血再灌注损伤。
Bioengineered. 2021 Dec;12(1):4972-4982. doi: 10.1080/21655979.2021.1954135.
4
Melatonin as a therapy in cardiac ischemia-reperfusion injury: Potential mechanisms by which MT2 activation mediates cardioprotection.褪黑素作为心脏缺血再灌注损伤的治疗方法:MT2 激活介导心脏保护的潜在机制。
J Adv Res. 2020 Sep 28;29:33-44. doi: 10.1016/j.jare.2020.09.007. eCollection 2021 Mar.
5
The LINC00477/miR-128 axis promotes the progression of polycystic ovary syndrome by regulating ovarian granulosa cell proliferation and apoptosis.LINC00477/miR-128 轴通过调节卵巢颗粒细胞增殖和凋亡促进多囊卵巢综合征的进展。
Reprod Biol Endocrinol. 2021 Feb 23;19(1):29. doi: 10.1186/s12958-021-00718-z.
6
Mitochondria as a therapeutic target for cardiac ischemia‑reperfusion injury (Review).线粒体作为心肌缺血再灌注损伤的治疗靶点(综述)。
Int J Mol Med. 2021 Feb;47(2):485-499. doi: 10.3892/ijmm.2020.4823. Epub 2020 Dec 16.
7
Dexmedetomidine at a dose of 1 µM attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress.剂量为1微摩尔的右美托咪定通过抑制内质网应激,减轻缺氧暴露3小时和复氧3小时条件下H9c2心肌细胞的损伤。
Exp Ther Med. 2021 Feb;21(2):132. doi: 10.3892/etm.2020.9564. Epub 2020 Dec 10.
8
GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.GIT1 过表达促进上皮-间充质转化并预测肝癌的不良预后。
Bioengineered. 2021 Dec;12(1):30-43. doi: 10.1080/21655979.2020.1855914.
9
Dexmedetomidine inhibits microglial activation through SNHG14/HMGB1 pathway in spinal cord ischemia-reperfusion injury mice.右美托咪定通过 SNHG14/HMGB1 通路抑制脊髓缺血再灌注损伤小鼠小胶质细胞的激活。
Int J Neurosci. 2022 Jan;132(1):77-88. doi: 10.1080/00207454.2020.1835901. Epub 2020 Dec 28.
10
Corrigendum to "Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis" [Biomed. Pharmacother. 125 (2020) 110001].《右美托咪定通过miR-208b-3p/Med13/ Wnt信号通路轴保护H9C2细胞免受缺氧/复氧损伤》的勘误 [《生物医学与药物治疗》125卷(2020年)110001]
Biomed Pharmacother. 2020 Oct;130:110841. doi: 10.1016/j.biopha.2020.110841. Epub 2020 Oct 5.